David Mehalick - 05 Jan 2024 Form 4 Insider Report for Coeptis Therapeutics Holdings, Inc. (COEP)

Role
CEO and President, Director, 10%+ Owner
Signature
/s/ David Mehalick
Issuer symbol
COEP
Transactions as of
05 Jan 2024
Net transactions value
+$16,747
Form type
4
Filing time
09 Jan 2024, 17:30:55 UTC
Previous filing
11 Dec 2023
Next filing
06 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COEP Common Stock Purchase $3,484 +5,050 +0.18% $0.6900 2,762,611 05 Jan 2024 Direct F1
transaction COEP Common Stock Purchase $4,020 +6,000 +0.22% $0.6700 2,768,611 08 Jan 2024 Direct F1
transaction COEP Common Stock Purchase $9,243 +14,004 +0.51% $0.6600 2,782,615 08 Jan 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 156,250 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days. exercise of options that are or will become exercisable in the next 60 days.